Amina Abbadi

Amina Abbadi is an accomplished researcher with extensive experience in nonclinical and translational program development. Currently serving as the Director and Research Lead at Abata Therapeutics since January 2023, Amina has previously held key positions such as Research Program Manager at Shriners Hospitals for Children and Scientific Group Lead at Harvard University, where Amina focused on gene therapy for junctional epidermolysis bullosa. Amina's tenure at Cleveland Clinic includes roles as Research Associate and K12 Scholar in Immersive Training in Glycosciences, highlighting the capability to secure significant grant funding and mentor future scientists. Amina holds a Ph.D. in Bioanalytical Clinical Chemistry from Cleveland State University-Cleveland Clinic.